BIOLINERX IN-LICENSES BL-3010 FROM GEVYS PHARMACEUTICALS

A A

BioLineRx, Ltd., Israel's leading drug development company, today announced that it has signed an exclusive worldwide licensing agreement with Gevys Pharmaceuticals Ltd. for the development and commercialization of BL-3010, a novel approach for the treatment of acute and chronic pain. Gevys's patented technology utilizes a combination of approved drugs to dramatically increase the potency of micro-doses of classical pain medications.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1910754)